His primary areas of study are Nuclear medicine, Positron emission tomography, Radiology, Radiation therapy and Lesion. His research integrates issues of Tomography and Lung in his study of Nuclear medicine. His Positron emission tomography study combines topics in areas such as Medical imaging, Misonidazole, 18F-Fluoromisonidazole, FMISO and Magnetic resonance imaging.
His research in Radiology intersects with topics in Carcinoma and Reproducibility. In his research, Colorectal cancer, Prospective cohort study and Rectum is intimately related to Positron emission, which falls under the overarching field of Radiation therapy. His work deals with themes such as Concordance, Tumor glycolysis and Total lesion glycolysis, which intersect with Lesion.
John L. Humm mostly deals with Nuclear medicine, Positron emission tomography, Radiology, Pathology and Radiation therapy. John L. Humm combines subjects such as Lesion and Medical imaging with his study of Nuclear medicine. John L. Humm studied Positron emission tomography and Tumor hypoxia that intersect with Misonidazole.
His work in Head and neck cancer and Radiation treatment planning are all subfields of Radiology research. His Pathology study integrates concerns from other disciplines, such as Hypoxia and Antibody, Monoclonal antibody. His work is dedicated to discovering how Dosimetry, Radioimmunotherapy are connected with Pharmacokinetics, Cancer research, Cerebrospinal fluid and Therapeutic index and other disciplines.
John L. Humm mainly focuses on Nuclear medicine, Internal medicine, Cancer research, Oncology and Radioimmunotherapy. The various areas that John L. Humm examines in his Nuclear medicine study include Pharmacokinetics, Hypoxia, Repeatability, Biopsy and Prostate cancer. His Prostate cancer research includes themes of Lesion and PET-CT.
His work on Apolipoprotein E is typically connected to Cognitive decline as part of general Internal medicine study, connecting several disciplines of science. His Radioimmunotherapy research incorporates themes from Radiology and Therapeutic index. Within one scientific family, John L. Humm focuses on topics pertaining to Neck dissection under Radiology, and may sometimes address concerns connected to Magnetic resonance imaging.
His primary scientific interests are in Nuclear medicine, Prostate cancer, Cancer research, Biodistribution and Pharmacokinetics. Fluorodeoxyglucose positron emission tomography is the focus of his Nuclear medicine research. The Prostate cancer study combines topics in areas such as Immunohistochemistry, Lesion and Biopsy.
John L. Humm interconnects Cancer cell, Brain tumor and Radiation therapy in the investigation of issues within Cancer research. The study incorporates disciplines such as Cerebrospinal fluid, Ommaya reservoir, Malignancy and Absorbed dose in addition to Biodistribution. His Pharmacokinetics research is multidisciplinary, incorporating elements of Adipose tissue and Urology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.
C.Clifton Ling;John Humm;Steven Larson;Howard Amols.
International Journal of Radiation Oncology Biology Physics (2000)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.
Howard I Scher;Tomasz M Beer;Celestia S Higano;Aseem Anand.
The Lancet (2010)
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.
Steven M. Larson;Yusuf Erdi;Timothy Akhurst;Madhu Mazumdar.
Molecular Imaging and Biology (1999)
Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding.
Yusuf E. Erdi;O. Mawlawi;Steven M. Larson;M. Imbriaco.
Radioimmunotherapy with alpha-emitting nuclides
Michael R. McDevitt;George Sgouros;Ronald D. Finn;John L. Humm.
European Journal of Nuclear Medicine and Molecular Imaging (1998)
Effect of Respiratory Gating on Quantifying PET Images of Lung Cancer
Sadek A. Nehmeh;Yusuf E. Erdi;Clifton C. Ling;Kenneth E. Rosenzweig.
The Journal of Nuclear Medicine (2002)
Four-dimensional (4D) PET/CT imaging of the thorax.
S. A. Nehmeh;Y. E. Erdi;T. Pan;A. Pevsner.
Medical Physics (2004)
Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography.
Juri G. Tjuvajev;Norbert Avril;Takamitsu Oku;Toshio Sasajima.
Cancer Research (1998)
Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
Yusuf E. Erdi;Kenneth Rosenzweig;Alev K. Erdi;Homer A. Macapinlac.
Radiotherapy and Oncology (2002)
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial
Chaitanya R Divgi;Neeta Pandit-Taskar;Achim A Jungbluth;Victor E Reuter.
Lancet Oncology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: